# GW Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gw-pharma

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Latest round: Series A (Sep 1, 2021)
- Investors on record: 5

## About

Based in Beijing, China and established in 2016, GW Pharma is a pharmaceutical company that focuses on the research and development of drugs in the spiritual field. In September 2021, the company raised an undisclosed amount of series A+ funding led by new investor Bio Venture. Other new investors China Growth Capital and E-town Sun Fund also participated in the round.

The company's main product is drug GW117. GW117 is applied to depression, anxiety and other diseases. It also has a CNS efficacy evaluation model and a rapid screening platform for new chemical entities.

## Funding rounds

- Series A, Sep 1, 2021 — China Growth Capital, YuanBio Venture, E-town Sun Fund
- Series A, Feb 23, 2021 — Cowin Capital, Dynamic Capital
- Angel, Aug 7, 2019 — Dynamic Capital

## Investors

- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Angel, Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series A
- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- E-town Sun Fund (https://capitalatlas.ai/funds/e-town-sun-fund) — Series A